Samsung Biologics Reports First Quarter 2026 Financial Results

B Recorded Q1’26 revenue of KRW 1,257 billion and operating profit of KRW 581 billion Performance driven by full utilization across Plants 1 through 4…
posteditor
posteditor
Articles: 17424

Other News